loader image
Friday, January 9, 2026
70.6 F
McAllen
- Advertisement -

AFib Is 3 Times More Widespread Than Doctors Thought

Translate to Spanish or other 102 languages!

Previous studies have reported that about 3.3 million peopleTrusted Source in the United States have atrial fibrillation (AFib) — a condition that causes the heart to beat in an irregular pattern or very rapidly. Image for illustration purposes
Previous studies have reported that about 3.3 million peopleTrusted Source in the United States have atrial fibrillation (AFib) — a condition that causes the heart to beat in an irregular pattern or very rapidly. Image for illustration purposes
- Advertisement -

New research suggests that there may be more than 10.5 million people in the United States living with atrial fibrillation, that is, three times more cases than experts had previously estimated. Image credit: Keith Brofsky/Getty Images.

  • Previous studies have reported that about 3 million people in the United States have atrial fibrillation (AFib). 
  • Researchers from the University of California – San Francisco discovered that AFib is three times more common in the U.S. than previously thought.
  • Over the course of the study, scientists found that people with AFib tended to be younger, less likely to be female, and more likely to have high blood pressure and diabetes.

Follow the link to Medical News Today for the full story:

https://www.medicalnewstoday.com/articles/afib-is-3-times-more-widespread-than-doctors-thought

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Wegovy® Pill, First Oral GLP‑1 for Weight Loss, Now Available Nationwide

Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time.

Historic Reset of U.S. Nutrition Policy with New Food Pyramid

Mega Doctor News WASHINGTON, D.C. – U.S. Department of Health and Human Services...

Metabolic Trigger Identified That Shuts Down Key Tumor‑Fighting Gene

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers from The University of Texas MD Anderson Cancer Center. 

Dry January Participation Linked to Noticeable Health Improvements

Mega Doctor News Medical News Today In 2013, Alcohol Change UK started the “Dry...
- Advertisement -
×